Oncology Biomarker Translation Services Market : Global Industry Analysis and Opportunity Assessment, 2036

Future Market Insights

Oncology Biomarker Translation Services Market

Key Insight

Biomarker discovery services lead the oncology biomarker translation services market with a 36.5% share in 2026, while genomic biomarkers account for 30.4% by biomarker type. Market growth depends on precision oncology, companion diagnostic development, and molecular testing adoption, while assay validation, regulatory compliance, and standardized data interpretation remain essential for broader clinical implementation.

July 30, 2026

Anurag Sharma

250 Pages

Cite this Report

Oncology Biomarker Translation Services Market

https://www.futuremarketinsights.com/reports/oncology-biomarker-translation-services-market

License

Buy Now

Summary ToC Companies

Key Players

Labcorp
IQVIA
Charles River Laboratories
Thermo Fisher Scientific Inc.
Roche Diagnostics
Illumina, Inc.
Guardant Health, Inc.
Foundation Medicine, Inc.
Eurofins Scientific
ICON plc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Oncology Biomarker Translation Services Market

Key Players

Similar Industry Reports